Belgium· BE-AMP-SAM665974-00
Livmarli 19 mg/ml
A maralixibat chloride product containing maralixibat chloride, registered in Belgium by Mirum Pharmaceuticals International. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Maralixibat chloride is registered in 11 of 19 countries.
Countries holding a registration under ATC A05AX04 (maralixibat chloride), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Maralixibat chloride · ATC A05AX04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Maralixibat Chloride
- Manufacturer
- Mirum Pharmaceuticals International
- Country
- Belgium (BE)
- ATC code
- A05AX04
- ATC class
- Maralixibat chloride
- Defined daily dose
- 28.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maralixibat chloride in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLIVMARLIMirum Pharmaceuticals International B.V., Amsterdam
- FinlandLivmarliMirum Pharmaceuticals International B.V.
- IrelandLivmarli 19 mg/mL oral solutionMirum Pharmaceuticals International B.V.
- IcelandLivmarliMirum Pharmaceuticals International B.V.
- SwedenLivmarli 19 mg/ml Oral lösningMirum Pharmaceuticals International B.V.
- United StatesLivmarliMirum Pharmaceuticals Inc.
- United KingdomLivmarli 10mg tabletsMirum Pharmaceuticals International BV
- SpainLIVMARLI 10 MG COMPRIMIDOSMirum Pharmaceuticals International B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Livmarli
- Liechtenstein · Livmarli
- Norway · Livmarli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9588d8c1-5391-4f3a-9e74-83455ef99d30 GET /v1/drugs/9588d8c1-5391-4f3a-9e74-83455ef99d30?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Livmarli 19 mg/ml",
"name_fr": "Livmarli 19 mg/ml",
"name_nl": "Livmarli 19 mg/ml",
"amp_code": "SAM665974-00",
"strengths": [
"19.0000",
"19.0000",
"364.5000"
],
"pack_count": 1,
"substances": [
"Maralixibat Chloride",
"Maralixibat",
"Disodium Edetate",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Maralixibat Chloride",
"authorisation_numbers": [
"EU/1/22/1704/002"
]
}See everything about maralixibat chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.